Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / CALL
-
Number of holders
-
0
-
Price
-
$86.02
Significant Holders of VERTEX PHARMACEUTICALS INC - CALL as of Q2 2016
7 filings reported holding 92532F900 - VERTEX PHARMACEUTICALS INC - CALL as of Q2 2016.
VERTEX PHARMACEUTICALS INC - CALL has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of shares
.
Largest 8 shareholders include CITADEL ADVISORS LLC (50,700 shares), GROUP ONE TRADING, L.P. (29,500 shares), Allianz Asset Management AG (24,700 shares), Timber Hill LLC (16,300 shares), SG Americas Securities, LLC (12,000 shares), SOCIETE GENERALE (12,000 shares), SIMPLEX TRADING, LLC (123 shares), and SABBY MANAGEMENT, LLC (609 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.